GemCo

Revitalization of Chemotherapeutics Using a Tumor Targeting Drug Delivery System (nanoparticle)

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Incorporation Type Not Incorporated
  • Website phiontx.co.uk

Company Summary

GemCo has the unique ability to deliver existing and off-patent chemotherapeutics selectively to tumors at over 30 fold over healthy tissues and cells.

Advantages include:
- Increased therapeutic effect with reduced off target toxicity
- Longer drug half-life
- Ability to bypass drug resistance mechanisms
- Revitalization of generic compounds with renewed patent protection

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free